Preclinical Activity of New [1,2]Oxazolo[5,4-e]isoindole Derivatives in Diffuse Malignant Peritoneal Mesothelioma-Reference-Cited by-同舟云学术

Preclinical Activity of New [1,2]Oxazolo[5,4-e]isoindole Derivatives in Diffuse Malignant Peritoneal Mesothelioma

Published:2016-07-26 Issue:15 Volume:59 Page:7223-7238
ISSN:0022-2623
Container-title:Journal of Medicinal Chemistry
language:en
Short-container-title:J. Med. Chem.

Author:

Spanò Virginia¹,Pennati Marzia²,Parrino Barbara¹,Carbone Anna¹,Montalbano Alessandra¹,Cilibrasi Vincenzo¹,Zuco Valentina²,Lopergolo Alessia²,Cominetti Denis²,Diana Patrizia¹,Cirrincione Girolamo¹,Barraja Paola¹,Zaffaroni Nadia²

Affiliation:

1. Dipartimento di Scienze e Tecnologie Biologiche Chimiche e Farmaceutiche (STEBICEF), Università degli Studi di Palermo, Via Archirafi 32, 90123 Palermo, Italy

2. Molecular Pharmacology Unit, Department of Experimental Oncology and Molecular Medicine, Fondazione IRCCS Istituto Nazionale Tumori, Via Amadeo 42, 20133 Milano, Italy

Funder

Ministero dell’Istruzione, dell’Università e della Ricerca

Associazione Italiana per la Ricerca sul Cancro

Publisher

American Chemical Society (ACS)

Subject

Drug Discovery,Molecular Medicine

Link

https://pubs.acs.org/doi/pdf/10.1021/acs.jmedchem.6b00777

Reference53 articles.

1. Advances in Malignant Mesothelioma

2. The Role of Perioperative Systemic Chemotherapy in Diffuse Malignant Peritoneal Mesothelioma Patients Treated with Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy